| Citation Matrix | Glossary HistCite Guide |
|
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia Armstrong SA, Staunton JE, Silverman LB, Pieters R, de Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ NATURE GENETICS 30 (1): 41-47 JAN 2002 and the citing papers. |
Nodes: 136,
Authors: 623,
Sources: 72,
Outer References: 4882
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 50 | 1 2002 AMERICAN JOURNAL OF PATHOLOGY 160(6):1941-1944
Kroll TG Molecular rearrangements and morphology in thyroid cancer | 0 | 2 |
| 2 | 1 | 68 | 2 2002 AMERICAN JOURNAL OF PATHOLOGY 161(5):1587-1595
Allander SV; Illei PB; Chen YD; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS Expression profiling of synovial sarcoma by cDNA microarrays - Association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation | 2 | 12 |
| 3 | 1 | 72 | 3 2002 ANALYTICAL BIOCHEMISTRY 307(2):191-201
Rush LJ; Plass C Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications | 0 | 1 |
| 4 | 2 | 107 | 4 2002 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 15(4):597-621
Kebriaei P; Anastasi J; Larson RA Acute lymphoblastic leukaemia: diagnosis and classification | 0 | 0 |
| 5 | 1 | 38 | 5 2002 BIOTECHNIQUES ():46-53
Sreekumar A; Chinnaiyan AM Using protein microarrays to study cancer | 0 | 1 |
| 6 | 1 | 9 | 6 2002 BLOOD 99(12):4647-4649
Hayette S; Tigaud I; Maguer-Satta V; Bartholin L; Thomas X; Charrin C; Gadoux M; Magaud JP; Rimokh R Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia | 0 | 3 |
| 7 | 1 | 151 | 7 2002 BLOOD 100(5):1532-1542
Gilliland DG; Griffin JD The roles of FLT3 in hematopoiesis and leukemia | 9 | 33 |
| 8 | 1 | 42 | 8 2002 BRITISH JOURNAL OF HAEMATOLOGY 118(4):999-1010
Isoyama K; Eguchi M; Hibi S; Kinukawa N; Ohkawa H; Kawasaki H; Kosaka Y; Oda T; Oda M; Okamura T; Nishimura S; Hayashi Y; Mori T; Imaizumi M; Mizutani S; Tsukimoto I; Kamada N; Ishii E Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96) | 4 | 5 |
| 9 | 1 | 12 | 9 2002 BRITISH JOURNAL OF HAEMATOLOGY 119(1):119-121
Imamura T; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Ishii E; Imashuku S Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement | 1 | 2 |
| 10 | 2 | 8 | 10 2002 CANCER CELL 1(2):109-110
Staudt LM It's ALL in the diagnosis | 1 | 6 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 11 | 1 | 25 | 11 2002 CANCER CELL 1(2):133-143
Yeoh EJ; Ross ME; Shurtleff SA; Williams WK; Patel D; Mahfouz R; Behm FG; Raimondi SC; Relling MV; Patel A; Cheng C; Campana D; Wilkins D; Zhou XD; Li JY; Liu HQ; Pui CH; Evans WE; Naeve C; Wong LS; Downing JR Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling | 63 | 136 |
| 12 | 2 | 33 | 12 2002 CANCER CELL 1(5):417-420
Gilliland DG; Tallman MS Focus on acute leukemias | 1 | 6 |
| 13 | 1 | 45 | 13 2002 CURRENT BIOLOGY 12(13):1076-1085
Dolznig H; Habermann B; Stangl K; Deiner EM; Moriggl R; Beug H; Mullner EW Apoptosis protection by the Epo target Bcl-X-L allows factor-independent differentiation of primary erythroblasts | 0 | 9 |
| 14 | 1 | 41 | 14 2002 CURRENT OPINION IN HEMATOLOGY 9(4):282-287
Ernst P; Wang J; Korsmeyer SJ The role of MLL in hematopoiesis and leukemia | 7 | 13 |
| 15 | 2 | 43 | 15 2002 CURRENT OPINION IN HEMATOLOGY 9(4):339-344
Armstrong SA; Hsieh JJD; Korsmeyer SJ Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias | 1 | 1 |
| 16 | 2 | 36 | 16 2002 CURRENT OPINION IN PHARMACOLOGY 2(5):551-554
Crowther DJ Applications of microarrays in the pharmaceutical industry | 0 | 1 |
| 17 | 4 | 28 | 17 2002 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 127(42):2216-2222
Kohlmann A; Schoch C; Schnittger S; Kern W; Haferlach T Diagnosis of leukemia using microarray technology | 0 | 0 |
| 18 | 1 | 55 | 18 2002 EMBO JOURNAL 21(16):4297-4306
Schulte CE; von Lindern M; Steinlein P; Beug H; Wiedemann LM MLL-ENL cooperates with SCF to transform primary avian multipotent cells | 4 | 7 |
| 19 | 1 | 111 | 19 2002 FRONTIERS IN BIOSCIENCE 7():D1782-D1797
Gelman IH The role of SSeCKS/Gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development | 0 | 2 |
| 20 | 1 | 16 | 20 2002 JAPANESE JOURNAL OF CANCER RESEARCH 93(8):849-856
Kaneta Y; Kagami Y; Katagiri T; Tsunoda T; Jin-nai I; Taguchi H; Hirai H; Ohnishi K; Ueda T; Emi N; Tomida A; Tsuruo T; Nakamura Y; Ohno R Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis | 0 | 3 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 21 | 1 | 64 | 21 2002 JOURNAL OF CLINICAL ONCOLOGY 20(7):1932-1941
Ramaswamy S; Golub TR DNA microarrays in clinical oncology | 6 | 49 |
| 22 | 1 | 10 | 22 2002 JOURNAL OF INVESTIGATIVE SURGERY 15(5):275-279
Rhodes DR; Chinnaiyan AM DNA microarrays: Implications for clinical medicine | 0 | 1 |
| 23 | 1 | 35 | 23 2002 LANCET 359(9321):1909-1915
Pui CH; Gaynon PS; Boyett JM; Chessells JM; Baruchel A; Kamps W; Silverman LB; Biondi A; Harms DO; Vilmer E; Schrappe M; Camitta B Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region | 12 | 23 |
| 24 | 1 | 48 | 24 2002 LANCET ONCOLOGY 3(6):349-356
Fey MF Impact of the Human Genome Project on the clinical management of sporadic cancers | 0 | 2 |
| 25 | 1 | 25 | 25 2002 MINERVA BIOTECNOLOGICA 14(3-4):273-279
Campanaro S; Romualdi C; De Pitta C; Fanin M; Celegato B; Pacchioni B; Trevisan S; Laveder P; Toppo S; Cagnin S; Valle G; Angelini C; Lanfranchi G Gene expression profiling in skeletal muscle using a dedicated microarray | 0 | 0 |
| 26 | 1 | 27 | 26 2002 MINERVA BIOTECNOLOGICA 14(3-4):281-290
Bicciato S; Luchini A; Di Bello C Disjoint PCA models for marker identification and classification of cancer types using gene expression data | 0 | 0 |
| 27 | 2 | 53 | 27 2002 MOLECULAR CELL 10(5):1107-1117
Milne TA; Briggs SD; Brock HW; Martin ME; Gibbs D; Allis CD; Hess JL MLL targets SET domain methyltransferase activity to Hox gene promoters | 14 | 37 |
| 28 | 0 | 47 | 28 2002 NATURE GENETICS 30(1):41-47
Armstrong SA; Staunton JE; Silverman LB; Pieters R; de Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia | 135 | 135 |
| 29 | 1 | 65 | 29 2002 NATURE GENETICS 32():474-479
Petricoin EF; Hackett JL; Lesko LJ; Puri RK; Gutman SI; Chumakov K; Woodcock J; Feigal DW; Zoon KC; Sistare FD Medical applications of microarray technologies: a regulatory science perspective | 0 | 16 |
| 30 | 1 | 98 | 30 2002 NATURE GENETICS 32():502-508
Slonim DK From patterns to pathways: gene expression data analysis comes of age | 2 | 42 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 31 | 2 | 2 | 31 2002 NATURE REVIEWS CANCER 2(4):248-248
Novak K Predicting outcome | 0 | 0 |
| 32 | 1 | 371 | 32 2002 ONCOGENE 21(21):3314-3333
Scheijen B; Griffin JD Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease | 0 | 14 |
| 33 | 1 | 84 | 33 2002 ONCOGENE 21(37):5804-5813
Wikman H; Kettunen E; Seppanen JK; Karjalainen A; Hollmen J; Anttila S; Knuutila S Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array | 0 | 10 |
| 34 | 1 | 55 | 34 2002 PHARMACOGENOMICS 3(3):403-415
Ringner M; Peterson C; Khan J Analyzing array data using supervised methods | 0 | 5 |
| 35 | 4 | 78 | 35 2002 PHARMACOGENOMICS 3(5):589-601
Chicurel ME; Dalma-Weiszhausz DD Microarrays in pharmacogenomics - advances and future promise | 0 | 6 |
| 36 | 1 | 48 | 36 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(15):10008-10013
Schoch C; Kohlmann A; Schnittger S; Brors B; Dugas M; Mergenthaler S; Kern W; Hiddemann W; Eils R; Haferlach T Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles | 13 | 24 |
| 37 | 2 | 29 | 37 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(15):10014-10019
Muschen M; Lee S; Zhou GL; Feldhahn N; Barath VS; Chen JJ; Moers C; Kronke M; Rowley JD; Wang SM Molecular portraits of B cell lineage commitment | 0 | 9 |
| 38 | 2 | 37 | 38 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(23):14925-14930
Qian ZJ; Fernald AA; Godley LA; Larson RA; Le Beau MM Expression profiling of CD34(+) hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia | 3 | 5 |
| 39 | 2 | 72 | 39 2002 TRENDS IN MOLECULAR MEDICINE 8(9):436-442
Collins EC; Rabbitts TH The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism | 1 | 4 |
| 40 | 2 | 44 | 40 2003 AMERICAN JOURNAL OF PATHOLOGY 162(3):925-932
Higgins JPT; Shinghal R; Gill H; Reese JH; Terris M; Cohen RJ; Fero M; Pollack JR; van de Rijn M; Brooks JD Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray | 0 | 3 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 41 | 2 | 58 | 41 2003 AMERICAN JOURNAL OF PATHOLOGY 163(6):2383-2395
Linn SC; West RB; Pollack JR; Zhu S; Hernandez-Boussard T; Nielsen TO; Rubin BP; Patel R; Goldblum JR; Siegmund D; Botstein D; Brown PO; Gilks CB; van de Rijn M Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans | 0 | 0 |
| 42 | 2 | 13 | 42 2003 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 27(3):414-415
Ladanyi M Translocation-based molecular diagnosis of sarcomas | 0 | 0 |
| 43 | 2 | 51 | 43 2003 ANNALS OF HEMATOLOGY 82(6):323-332
Schwaenen C; Wessendorf S; Kestler HA; Dohner H; Lichter P; Bentz M DNA microarray analysis in malignant lymphomas | 0 | 1 |
| 44 | 1 | 93 | 44 2003 ANTICANCER RESEARCH 23(3A):2101-2110
Maroulakou IG; Spyropoulos DD The study of HOX gene function in hematopoietic, breast and lung carcinogenesis | 0 | 0 |
| 45 | 2 | 14 | 45 2003 BIOINFORMATICS 19(1):71-78
Li JY; Liu HQ; Downing JR; Yeoh AEJ; Wong LS Simple rules underlying gene expression profiles of more than six subtypes of acute lymphoblastic leukemia (ALL) patients | 1 | 5 |
| 46 | 1 | 20 | 46 2003 BIOINFORMATICS 19(5):571-578
Bicciato S; Luchini A; Di Bello C PCA disjoint models for multiclass cancer analysis using gene expression data | 0 | 2 |
| 47 | 2 | 22 | 47 2003 BIOINFORMATICS 19(13):1620-1627
Pavlidis P; Li QH; Noble WS The effect of replication on gene expression microarray experiments | 0 | 0 |
| 48 | 1 | 39 | 48 2003 BIOINFORMATICS 19(16):2131-2140
Hsu AL; Tang SL; Halgamuge SK An unsupervised hierarchical dynamic self-organizing approach to cancer class discovery and marker gene identification in microarray data | 0 | 0 |
| 49 | 1 | 20 | 49 2003 BIOTECHNIQUES ():55-61
Draghici S; Khatri P; Shah A; Tainsky MA Assessing the functional bias of commercial microarrays using the onto-compare database | 0 | 0 |
| 50 | 1 | 49 | 50 2003 BIOTECHNOLOGY AND BIOENGINEERING 81(5):594-606
Bicciato S; Pandin M; Didone G; Di Bello C Pattern identification and classification in gene expression data using an autoassociative neural network model | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 51 | 1 | 35 | 51 2003 BLOOD 101(4):1270-1276
Stam RW; den Boer ML; Meijerink JPP; Ebus MEG; Peters GJ; Noordhuis P; Janka-Schaub GE; Armstrong SA; Korsmeyer SJ; Pieters R Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia | 1 | 4 |
| 52 | 4 | 52 | 52 2003 BLOOD 102(1):262-268
Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation | 8 | 10 |
| 53 | 4 | 37 | 53 2003 BLOOD 102(5):1849-1856
Yagi T; Morimoto A; Eguchi M; Hibi S; Sako M; Ishii E; Mizutani S; Imashuku S; Ohki M; Ichikawa H Identification of a gene expression signature associated with pediatric AML prognosis | 4 | 4 |
| 54 | 3 | 48 | 54 2003 BLOOD 102(6):2198-2204
Libura M; Asnafi V; Tu A; Delabesse E; Tigaud I; Cymbalista F; Bennaceur-Griscelli A; Villarese P; Solbu G; Hagemeijer A; Beldjord K; Hermine O; Macintyre E FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress | 0 | 0 |
| 55 | 2 | 46 | 55 2003 BLOOD 102(7):2395-2402
Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases | 0 | 1 |
| 56 | 4 | 38 | 56 2003 BLOOD 102(8):2951-2959
Ross ME; Zhou XD; Song GC; Shurtleff SA; Girtman K; Williams WK; Liu HC; Mahfouz R; Raimondi SC; Lenny N; Patel A; Downing JR Classification of pediatric acute lymphoblastic leukemia by gene expression profiling | 1 | 1 |
| 57 | 2 | 96 | 57 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(4):523-538
Kottaridis PD; Gale RE; Linch DC FLT3 mutations and leukaemia | 0 | 0 |
| 58 | 4 | 37 | 58 2003 CANCER CELL 3(2):161-171
So CW; Karsunky H; Passegue E; Cozzio A; Weissman IL; Cleary ML MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice | 4 | 8 |
| 59 | 4 | 50 | 59 2003 CANCER CELL 3(2):173-183
Armstrong SA; Kung AL; Mabon ME; Silverman LB; Stam RW; Den Boer ML; Pieters R; Kersey JH; Sallan SE; Fletcher JA; Golub TR; Griffin JD; Korsmeyer SJ Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification | 14 | 21 |
| 60 | 5 | 14 | 60 2003 CANCER CELL 4(2):81-83
Hsu K; Look AT Turning on a dimer: New insights into MLL chimeras | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 61 | 3 | 62 | 61 2003 CANCER CELL 4(3):197-207
Martin ME; Milne TA; Bloyer S; Galoian K; Shen WP; Gibbs D; Brock HW; Slany R; Hess JL Dimerization of MLL fusion proteins immortalizes hematopoietic cells | 1 | 2 |
| 62 | 1 | 20 | 62 2003 CANCER GENETICS AND CYTOGENETICS 145(1):54-59
Dube S; Fetni R; Hazourli S; Champagne M; Lemieux N Rearrangement of the MLL gene and a region proximal to the RAR alpha gene in a case of acute myelocytic leukemia M5 with a t(11;17)(q23;q21) | 0 | 0 |
| 63 | 1 | 41 | 63 2003 CANCER GENETICS AND CYTOGENETICS 145(2):152-160
Nagata T; Takahashia Y; Ishii Y; Asai S; Nishida Y; Murata A; Koshinaga T; Fukuzawa M; Hamazaki M; Asami K; Ito E; Ikeda H; Takamatsu H; Koike K; Kikuta A; Kuroiwa M; Watanabe A; Kosaka Y; Fujita H; Miyake M; Mugishima H Transcriptional profiling in hepatoblastornas using high-density oligonucleotide DNA array | 0 | 0 |
| 64 | 4 | 46 | 64 2003 CANCER RESEARCH 63(16):4882-4887
Tsutsumi S; Taketani T; Nishimura K; Ge XJ; Taki T; Sugita K; Ishii E; Hanada R; Ohki M; Aburatani H; Hayashi Y Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements | 2 | 2 |
| 65 | 2 | 77 | 65 2003 CANCER RESEARCH 63(17):5428-5437
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ A molecular fingerprint for medulloblastoma | 0 | 0 |
| 66 | 4 | 166 | 66 2003 CANCER TREATMENT REVIEWS 29(1):31-44
Rubnitz JE; Pui CH Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia | 0 | 0 |
| 67 | 4 | 9 | 67 2003 CELL 115(3):248-250
Gilliland DG Proteolytic processing in development and leukemogenesis | 0 | 0 |
| 68 | 5 | 49 | 68 2003 CELL 115(3):293-303
Hsieh JJD; Cheng EHY; Korsmeyer SJ Taspase1: A threonine aspartase required for cleavage of MLL and proper HOX gene expression | 0 | 0 |
| 69 | 3 | 61 | 69 2003 CLINICAL AND LABORATORY HAEMATOLOGY 25(4):209-220
Levene AP; Morgan GJ; Davies FE The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies | 0 | 0 |
| 70 | 1 | 29 | 70 2003 CLINICAL CANCER RESEARCH 9(5):1792-1800
Barden CB; Shister KW; Zhu BX; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ Classification of follicular thyroid tumors by molecular signature: Results of gene profiling | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 71 | 1 | 37 | 71 2003 CLINICAL CANCER RESEARCH 9(12):4483-4493
Yao Q; Nishiuchi R; Li QZ; Kumar AR; Hudson WA; Kersey JH FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases | 0 | 0 |
| 72 | 2 | 89 | 72 2003 CLINICAL IMMUNOLOGY 109(1):80-88
Esteller M Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg | 0 | 0 |
| 73 | 1 | 19 | 73 2003 CURRENT OPINION IN BIOTECHNOLOGY 14(1):74-81
Kingsmore SF; Patel DD Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification | 0 | 4 |
| 74 | 2 | 37 | 74 2003 CURRENT OPINION IN CELL BIOLOGY 15(2):213-220
Ciro M; Bracken AP; Helin K Profiling cancer | 0 | 1 |
| 75 | 5 | 83 | 75 2003 CURRENT OPINION IN HEMATOLOGY 10(4):290-296
Silverman LB; Sallan SE Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment | 0 | 1 |
| 76 | 4 | 149 | 76 2003 CURRENT OPINION IN ONCOLOGY 15(1):23-35
Ravindranath Y Recent advances in pediatric acute lymphoblastic and myeloid leukemia | 0 | 0 |
| 77 | 3 | 22 | 77 2003 CYTOMETRY PART B-CLINICAL CYTOMETRY 55B(1):29-36
Kern W; Kohlmann A; Wuchter C; Schnittger S; Schoch C; Mergenthaler S; Ratei R; Ludwig WD; Hiddemann W; Haferlach T Correlation of protein expression and gene expression in acute leukemia | 0 | 2 |
| 78 | 1 | 101 | 78 2003 EUROPEAN JOURNAL OF CONTROL 9(2-3):237-278
De Moor B; Marchal K; Mathys J; Moreau Y Bioinformatics: Organisms from Venus, technology from Jupiter, algorithms from Mars | 0 | 0 |
| 79 | 2 | 100 | 79 2003 GENE 305(2):141-150
Cunliffe VT Memory by modification: the influence of chromatin structure on gene expression during vertebrate development | 0 | 3 |
| 80 | 5 | 49 | 80 2003 GENES & DEVELOPMENT 17(18):2298-2307
Ayton PM; Cleary ML Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9 | 3 | 3 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 81 | 6 | 31 | 81 2003 GENES & DEVELOPMENT 17(24):3029-3035
Cozzio A; Passegue E; Ayton PM; Karsunky H; Cleary ML; Weissman IL Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors | 0 | 0 |
| 82 | 3 | 29 | 82 2003 GENES CHROMOSOMES & CANCER 37(2):149-158
Debernardi S; Lillington DM; Chaplin T; Tomlinson S; Amess J; Rohatiner A; Lister TA; Young BD Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events | 3 | 3 |
| 83 | 4 | 25 | 83 2003 GENES CHROMOSOMES & CANCER 37(4):396-405
Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T Molecular characterization of acute leukemias by use of microarray technology | 3 | 4 |
| 84 | 1 | 80 | 84 2003 HUMAN PATHOLOGY 34(4):352-358
Bagg A Clinical applications of molecular genetic testing in hematologic malignancies: Advantages and limitations | 0 | 0 |
| 85 | 4 | 62 | 85 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):383-389
Pui CH; Ribeiro RC International collaboration on childhood leukemia | 0 | 0 |
| 86 | 14 | 125 | 86 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):390-401
Eguchi M; Eguchi-Ishimae M; Greaves M The role of the MLL gene in infant leukemia | 0 | 0 |
| 87 | 7 | 186 | 87 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):402-413
Pieters R; den Boer ML Molecular pharmacodynamics in childhood leukemia | 0 | 0 |
| 88 | 12 | 36 | 88 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):414-420
Hayashi Y Gene expression profiling in childhood acute leukemia: Progress and perspectives | 0 | 0 |
| 89 | 1 | 43 | 89 2003 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 11(6):713-721
Nagata T; Takahashi Y; Ishii Y; Asai S; Sugahara M; Nishida Y; Murata A; Chin M; Schichino H; Koshinaga T; Fukuzawa M; Mugishima H Profiling of genes differentially expressed between fetal liver and postnatal liver using high-density oligonucleotide DNA array | 0 | 0 |
| 90 | 4 | 49 | 90 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 23(3):617-625
Morikawa J; Li H; Kim S; Nishii K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RAR alpha) | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 91 | 1 | 26 | 91 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 23(3):681-691
Kaneta Y; Kagami Y; Tsunoda T; Ohno R; Nakamura Y; Katagiri T Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray | 0 | 0 |
| 92 | 1 | 54 | 92 2003 JOURNAL OF BIOLOGICAL RHYTHMS 18(2):96-105
Sato TK; Panda S; Kay SA; Hogenesch JB DNA arrays: Applications and implications for circadian biology | 0 | 2 |
| 93 | 1 | 51 | 93 2003 JOURNAL OF CELL SCIENCE 116(7):1305-1318
Seelenmeyer C; Wegehingel S; Lechner J; Nickel W The cancer antigen CA125 represents a novel counter receptor for galectin-1 | 0 | 2 |
| 94 | 1 | 52 | 94 2003 JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 23(3):310-319
Tang Y; Nee AC; Lu AG; Ran RQ; Sharp FR Blood genomic expression profile for neuronal injury | 0 | 1 |
| 95 | 2 | 47 | 95 2003 JOURNAL OF HEPATOLOGY 39(6):1004-1012
Kurokawa Y; Matoba R; Takemasa I; Nakamori S; Tsujie M; Nagano H; Dono K; Umeshita K; Sakon M; Ueno N; Kita H; Oba S; Ishii S; Kato K; Monden M Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study | 0 | 0 |
| 96 | 1 | 38 | 96 2003 JOURNAL OF LEUKOCYTE BIOLOGY 74(4):602-610
Hoffmann R; Seidl T; Bruno L; Dugas M Developmental markers of B cells are superior to those of T cells for identification of stages with distinct gene expression profiles | 0 | 0 |
| 97 | 1 | 141 | 97 2003 JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 25(5):348-361
Isaacs H Fetal and neonatal leukemia | 0 | 0 |
| 98 | 2 | 69 | 98 2003 LABORATORY INVESTIGATION 83(3):305-316
Bertucci F; Viens P; Tagett R; Nguyen C; Houlgatte R; Birnbaum D DNA arrays in clinical oncology: Promises and challenges | 0 | 1 |
| 99 | 2 | 8 | 99 2003 LEUKEMIA 17(3):636-636
Lo Nigro L; Bottino D; Panarello C; Mirabile E; Rapella AM; Di Cataldo A; Schiliro G Prognostic impact of t(9;11) in childhood acute myeloid leukemia (AML) | 0 | 0 |
| 100 | 2 | 41 | 100 2003 LEUKEMIA 17(4):700-706
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements | 2 | 3 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 101 | 2 | 15 | 101 2003 LEUKEMIA 17(7):1324-1332
Staal FJT; van der Burg M; Wessels LFA; Barendregt BH; Baert MRM; van den Burg CMM; Van Huffel C; Langerak AW; van der Velden VHJ; Reinders MJT; van Dongen JJM DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers | 1 | 1 |
| 102 | 2 | 35 | 102 2003 LEUKEMIA 17(8):1557-1565
De Zen L; Bicciato S; Kronnie GT; Basso G Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification | 0 | 0 |
| 103 | 2 | 33 | 103 2003 LEUKEMIA 17(8):1589-1595
Schwartz S; Rieder H; Schlager B; Burmeister T; Fischer L; Thiel E Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype | 0 | 0 |
| 104 | 2 | 52 | 104 2003 LEUKEMIA 17(9):1891-1900
Qiu J; Gunaratne P; Peterson LE; Khurana D; Walsham N; Loulseged H; Karni RJ; Roussel E; Gibbs RA; Margolin JF; Gingras MC Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR | 0 | 0 |
| 105 | 7 | 200 | 105 2003 LEUKEMIA 17(12):2358-2382
Larson RA; Daley GQ; Schiffer CA; Porcu P; Pui CH; Marie JP; Steelman LS; Bertrand FE; McCubrey JA Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002 | 0 | 0 |
| 106 | 5 | 43 | 106 2003 LEUKEMIA 17(12):2454-2459
Bertrand FE; Spengeman JD; Shah N; LeBien TW B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression | 0 | 0 |
| 107 | 1 | 21 | 107 2003 MACHINE LEARNING 52(1-2):11-30
Hsing T; Attoor S; Dougherty E Relation between permutation-test P values and classifier error estimates | 0 | 0 |
| 108 | 2 | 36 | 108 2003 MOLECULAR AND CELLULAR BIOLOGY 23(1):186-194
Hsieh JJD; Ernst P; Erdjument-Bromage H; Tempst P; Korsmeyer SJ Proteolytic cleavage of MLL generates a complex of N-and C-terminal fragments that confers protein stability and subnuclear localization | 6 | 10 |
| 109 | 2 | 35 | 109 2003 MOLECULAR CANCER THERAPEUTICS 2(7):671-677
Kees UR; Ford J; Watson M; Murch A; Ringner M; Walker RL; Meltzer P Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease | 0 | 0 |
| 110 | 1 | 28 | 110 2003 NATURE 423(6938):452-456
Jumaa H; Bossaller L; Portugal K; Storch B; Lotz M; Flemming A; Schrappe M; Postila V; Riikonen P; Pelkonen J; Niemeyer CM; Reth M Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia | 0 | 4 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 111 | 2 | 29 | 111 2003 NATURE GENETICS 34(1):85-90
Cheok MH; Yang WL; Pui CH; Downing JR; Cheng C; Naeve CW; Relling MV; Evans WE Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 3 | 8 |
| 112 | 5 | 151 | 112 2003 NATURE REVIEWS CANCER 3(9):639-649
Greaves MF; Wiemels J Origins of chromosome translocations in childhood leukaemia | 1 | 2 |
| 113 | 2 | 128 | 113 2003 NATURE REVIEWS CANCER 3(9):650-U1
Stirewalt DL; Radich JP The role of FLT3 in haematopoietic malignancies | 0 | 1 |
| 114 | 4 | 40 | 114 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(18):1777-1785
Staudt LM Molecular diagnosis of the hematologic cancers | 1 | 7 |
| 115 | 1 | 166 | 115 2003 NEW TRENDS IN CANCER FOR THE 21ST CENTURY 532():121-140
Sattler M; Scheijen B; Weisberg E; Griffin JD Mutated tyrosine kinases as therapeutic targets in myeloid leukemias | 0 | 1 |
| 116 | 2 | 38 | 116 2003 ONCOGENE 22(11):1629-1637
Zeisig BB; Garcia-Cuellar MP; Winkler TH; Slany RK The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell | 2 | 3 |
| 117 | 1 | 38 | 117 2003 ONCOGENE 22(22):3395-3406
Srinivasan RS; de Erkenez AC; Hemenway CS The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor | 0 | 0 |
| 118 | 3 | 67 | 118 2003 ONCOGENE 22(23):3655-3668
Schraets D; Lehmann T; Dingermann T; Marschalek R MLL-mediated transcriptional gene regulation investigated by gene expression profiling | 1 | 1 |
| 119 | 1 | 29 | 119 2003 ONCOGENE 22(36):5720-5728
Ota J; Yamashita Y; Okawa K; Kisanuki H; Fujiwara S; Ishikawa M; Choi YL; Ueno S; Ohki R; Koinuma K; Wada T; Compton D; Kadoya T; Mano H Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders | 0 | 1 |
| 120 | 3 | 59 | 120 2003 PATHOLOGIE BIOLOGIE 51(6):337-345
Dastugue N The interest of standard and molecular cytogenetics for diagnosis of acute leukemia | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 121 | 3 | 49 | 121 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(13):7853-7858
Rozovskaia T; Ravid-Amir O; Tillib S; Getz G; Feinstein E; Agrawal H; Nagler A; Rappaport EF; Issaeva I; Matsuo Y; Kees UR; Lapidot T; Lo Coco F; Foa R; Mazo A; Nakamura T; Croce CM; Cimino G; Domany E; Canaani E Expression profiles. of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements | 4 | 4 |
| 122 | 2 | 66 | 122 2003 RECENT PROGRESS IN HORMONE RESEARCH, VOL 58 58():25-53
Copland JA; Davies PJ; Shipley GL; Wood CG; Luxon BA; Urban RJ The use of DNA microarrays to assess clinical samples: The transition from bedside to bench to bedside | 0 | 1 |
| 123 | 1 | 9 | 123 2003 SCIENTIST ():22-24
Lewis R DNA expression profiling: A new lens on cancer - The seeds of spread may be sown early | 0 | 0 |
| 124 | 9 | 43 | 124 2003 SEMINARS IN HEMATOLOGY 40(4):268-273
Armstrong SA; Golub TR; Korsmeyer SJ MLL-rearranged leukemias: Insights from gene expression profiling | 0 | 0 |
| 125 | 5 | 36 | 125 2003 SEMINARS IN HEMATOLOGY 40(4):274-280
Ferrando AA; Look AT Gene expression profiling in T-cell acute lymphoblastic leukemia | 0 | 0 |
| 126 | 11 | 64 | 126 2003 SEMINARS IN HEMATOLOGY 40(4):281-295
Haferlach T; Kohlmann A; Kern W; Hiddemann W; Schnittger S; Schoch C Gene expression profiling as a tool for the diagnosis of acute leukemias | 0 | 0 |
| 127 | 2 | 75 | 127 2003 TISSUE ANTIGENS 62(2):93-103
Boussioutas A; Haviv I Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines | 0 | 0 |
| 128 | 1 | 37 | 128 2003 TRENDS IN CELL BIOLOGY 13(3):151-156
Panda S; Sato TK; Hampton GM; Hogenesch JB An array of insights: application of DNA chip technology in the study of cell biology | 0 | 3 |
| 129 | 2 | 37 | 129 2003 TRENDS IN MOLECULAR MEDICINE 9(1):5-10
Hampton GM; Frierson HF Classifying human cancer by analysis of gene expression | 0 | 1 |
| 130 | 5 | 32 | 130 2004 BLOOD 103(1):229-235
Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 131 | 2 | 55 | 131 2004 BLOOD 103(1):267-274
Zheng R; Levis M; Piloto O; Brown P; Baldwin BR; Gorin NC; Beran M; Zhu ZP; Ludwig D; Hicklin D; Witte L; Li YW; Small D FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells | 0 | 0 |
| 132 | 5 | 28 | 132 2004 LEUKEMIA 18(1):63-71
Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients | 0 | 0 |
| 133 | 3 | 61 | 133 2004 LEUKEMIA 18(2):227-232
Drexler HG; Quentmeier H; MacLeod RAF Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations | 0 | 0 |
| 134 | 6 | 26 | 134 2004 LEUKEMIA & LYMPHOMA 45(3):567-574
Quentmeier H; Dirks WG; Macleod RAF; Reinhardt J; Zaborski M; Drexler HG Expression of HOX genes in acute leukemia cell lines with and without MLL translocations | 0 | 0 |
| 135 | 2 | 31 | 135 2004 LEUKEMIA RESEARCH 28(1):1-7
Bruchova H; Kalinova M; Brdicka R Array-based analysis of gene expression in childhood acute lymphoblastic leukemia | 0 | 0 |
| 136 | 8 | 52 | 136 2004 MOLECULAR AND CELLULAR BIOLOGY 24(2):617-628
Zeisig BB; Milne T; Garcia-Cuellar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization | 0 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.01.07